This inventor holds 33 USPTO granted patents and 4 published patent applications, plus 7 CIPO patents and 12 EPO patents, primarily in Neurodegenerative Disorders. Top assignees: Amicus Therapeutics, Inc., Ortho-Mcneil Pharmaceutical Corp., Janssen Pharmaceutica Nv. Active years: 1997-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cranbury, NJ (US) (2015)
- Horsham, PA (US) (1997 - 2023)
Company Filing History:
20 out of 161 
9 out of 363 
2 out of 2,100 
Years Active: 1997-2026
Areas of Expertise:
Title: Robert E Boyd: A Pioneer in Biopharmaceutical Innovations
Introduction
Robert E Boyd, based in Horsham, Pennsylvania, is a prominent inventor with a remarkable portfolio of 32 patents to his name. His work primarily focuses on innovative treatments for various genetic and degenerative diseases, showcasing his dedication to enhancing healthcare through scientific advancements.
Latest Patents
Among his latest contributions to the field, Boyd has developed a groundbreaking method for treating Pompe disease utilizing 1-deoxynojirimycin derivatives. This method is designed to enhance the activity of mutant or wild-type α-glucosidase enzymes both in vitro and in vivo by using a specific pharmacological chaperone. Additionally, he has created a treatment protocol that includes administering a chaperone small molecule compound, a derivative of 1-deoxynojirimycin, which may significantly improve patient outcomes.
Another noteworthy patent focuses on preventing and treating degenerative disorders of the central nervous system and lysosomal storage disorders. His innovative approach provides novel compounds and methodologies aimed at tackling severe conditions such as Parkinson's disease, Alzheimer's disease, and Gaucher's disease.
Career Highlights
Robert E Boyd has had a distinguished career in the biopharmaceutical industry, having contributed his expertise to notable companies such as Amicus Therapeutics, Inc. and Ortho-McNeil Pharmaceutical Corporation. His tenure in these organizations has allowed him to be a part of pioneering research initiatives that push the boundaries of medical science.
Collaborations
Throughout his career, Boyd has collaborated with esteemed colleagues such as Gary Lee and Philip J Rybczynski. These partnerships have fostered an environment of innovative thinking and have been instrumental in driving forward the research and development efforts that result in his numerous patents.
Conclusion
Robert E Boyd stands out as a leading inventor who has significantly influenced the landscape of biopharmaceutical innovations. His extensive work on treatments for rare diseases and neurological disorders underscores the impact of dedicated research and collaboration in driving forward medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile